Disodium cromoglycate in treatment of asthmatic children

Area of Science:

• Pediatrics
• Allergy and Immunology
• Pharmacology

Background:

• Asthma is a chronic respiratory condition affecting children worldwide.
• Current asthma management often involves multiple medications with potential side effects.
• There is a need for effective prophylactic asthma treatments.

Purpose of the Study:

• To evaluate the efficacy of disodium cromoglycate (DSCG) in pediatric asthma patients.
• To assess the impact of DSCG on asthma symptoms and overall well-being.
• To determine if DSCG can reduce the reliance on other asthma medications.

Main Methods:

• A study was conducted with 38 children diagnosed with asthma.
• Disodium cromoglycate (DSCG) was administered to the participants.
• Clinical observations and patient/family reports were used to assess outcomes.

Main Results:

• Nearly all participants showed marked improvement in chest symptoms, wheezing, and coughing.
• Significant improvements were observed in weight gain, personality, school attendance, and physical activity.
• The use of other medications, including steroid therapy and aerosol bronchodilators, was substantially reduced.
• No adverse side effects were reported during the study.

Conclusions:

• Disodium cromoglycate (DSCG) plays a crucial role in managing selected pediatric asthma cases.
• DSCG demonstrates significant prophylactic benefits, improving multiple aspects of a child's health and daily life.
• The drug is effective as a preventative measure, not for acute symptom relief.